UBS Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-681
| Closed | -$395 | – | 10715 |
|
|
2024
Q3 | $395 | Sell |
681
-84,134
| -99% | -$47.2K | ﹤0.01% | 8958 |
|
|
2024
Q2 | $52.4K | Sell |
84,815
-98,183
| -54% | -$83K | ﹤0.01% | 6653 |
|
|
2024
Q1 | $470K | Sell |
182,998
-14,670
| -7% | -$35.8K | ﹤0.01% | 5253 |
|
|
2023
Q4 | $403K | Sell |
197,668
-68,259
| -26% | -$125K | ﹤0.01% | 5268 |
|
|
2023
Q3 | $457K | Sell |
265,927
-1,397
| -0.5% | -$2.48K | ﹤0.01% | 4730 |
|
|
2023
Q2 | $521K | Buy |
267,324
+54,391
| +26% | +$127K | ﹤0.01% | 4793 |
|
|
2023
Q1 | $592K | Sell |
212,933
-2,841
| -1% | -$8.12K | ﹤0.01% | 4560 |
|
|
2022
Q4 | $744K | Sell |
215,774
-4,646
| -2% | -$13.3K | ﹤0.01% | 4335 |
|
|
2022
Q3 | $566K | Buy |
220,420
+30,910
| +16% | +$98.4K | ﹤0.01% | 4221 |
|
|
2022
Q2 | $459K | Sell |
189,510
-710
| -0.4% | -$1.86K | ﹤0.01% | 4319 |
|
|
2022
Q1 | $784K | Sell |
190,220
-157,938
| -45% | -$837K | ﹤0.01% | 4339 |
|
|
2021
Q4 | $4.48M | Buy |
348,158
+251,984
| +262% | +$2.79M | ﹤0.01% | 2940 |
|
|
2021
Q3 | $1.04M | Buy |
96,174
+95,687
| +19,648% | +$871K | ﹤0.01% | 4174 |
|
|
2021
Q2 | $5K | Sell |
487
-8,389
| -95% | -$77.6K | ﹤0.01% | 8585 |
|
|
2021
Q1 | $84K | Buy |
8,876
+3,586
| +68% | +$49.4K | ﹤0.01% | 6102 |
|
|
2020
Q4 | $21K | Buy |
+5,290
| New | +$16K | ﹤0.01% | 6924 |
|
|
2020
Q3 | – | Sell |
-6,353
| Closed | -$42K | – | 8508 |
|
|
2020
Q2 | $42K | Sell |
6,353
-3,378
| -35% | -$22.7K | ﹤0.01% | 6018 |
|
|
2020
Q1 | $57K | Sell |
9,731
-18,816
| -66% | -$158K | ﹤0.01% | 5731 |
|
|
2019
Q4 | $256K | Buy |
28,547
+8,244
| +41% | +$68.7K | ﹤0.01% | 5422 |
|
|
2019
Q3 | $175K | Buy |
20,303
+15,801
| +351% | +$160K | ﹤0.01% | 5345 |
|
|
2019
Q2 | $50K | Buy |
4,502
+3,702
| +463% | +$42.3K | ﹤0.01% | 5937 |
|
|
2019
Q1 | $11K | Sell |
800
-2,243
| -74% | -$30K | ﹤0.01% | 6764 |
|
|
2018
Q4 | $47K | Buy |
+3,043
| New | +$58.1K | ﹤0.01% | 6145 |
|
Other funds holding GRTS
UBS Group's GRTS Position: Q4 2024 in Review
UBS Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 681 shares — an estimated $395 sold.
UBS Group first reported a position in GRTS in Q4 2018 and held it in 23 quarters. The position peaked at $4.48M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- UBS Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 681 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $395.
- UBS Group first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 23 quarters.
- UBS Group's Gritstone bio, Inc. Common Stock position peaked at $4.48M in Q4 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.